Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer-Reference-Cited by-同舟云学术

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer

Published:2018-01-30 Issue:9 Volume:124 Page:1904-1911
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Litvak Anya¹,Batukbhai Bhavina²,Russell Stuart D.¹,Tsai Hua-Ling³,Rosner Gary L.³,Jeter Stacie C.³,Armstrong Deborah³,Emens Leisha A.³,Fetting John³,Wolff Antonio C.³,Silhy Raquel³,Stearns Vered³,Connolly Roisin M.³^ORCID

Affiliation:

1. Department of Medicine; The Johns Hopkins Hospital; Baltimore Maryland

2. Department of Medicine; Sinai Hospital; Baltimore Maryland

3. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins School of Medicine; Baltimore Maryland

Funder

Sidney Kimmel Comprehensive Cancer Center Core Grant

AVON Center of Excellence

Avon Foundation for Women

National Cancer Institute

SKCCC Core

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference37 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin.,2016

2. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2;Slamon;N Engl J Med.,2001

3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science.,1987

4. Adjuvant trastuzumab in HER2-positive breast cancer;Slamon;N Engl J Med.,2010

5. Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31;Perez;J Clin Oncol.,2011

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reducing racial and ethnic disparities in cardiovascular outcomes among cancer survivors;Current Oncology Reports;2024-07-13

2. Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial;Medical Oncology;2024-07-08

3. Health Equity in Cardio-oncology: Investigating Mechanistic Causes Behind Adverse Cardiovascular and Cancer Health;Current Treatment Options in Cardiovascular Medicine;2024-05-28

4. Disparities in Cardiovascular Disease-Related Outcomes Among Cancer Survivors in the United States: A Systematic Review of the Literature;Heart, Lung and Circulation;2024-05

5. Unravelling race inequities in cardiovascular disease mortality among cancer survivors: new insights and future directions;International Journal of Epidemiology;2024-04-11